Lung stem cell infusion shows promise in early IPF trial

This early-stage study tests whether a person's own lung stem cells, grown from a small biopsy and given through an IV, are safe for treating idiopathic pulmonary fibrosis (IPF). Twenty-four adults with IPF will receive either a low or high dose of stem cells or standard care. The main goal is to check for side effects over two years, while also looking at lung function and scarring on CT scans.